Inhibition of tumor angiogenesis by cannabinoids

@article{Blazquez2003InhibitionOT,
  title={Inhibition of tumor angiogenesis by cannabinoids},
  author={Cristina Blázquez and Mar{\'i}a Llanos Casanova and Anna M. Planas and Teresa G{\'o}mez del Pulgar and Concepci{\'o}n Villanueva and Mar{\'i}a Jes{\'u}s Fern{\'a}ndez-Ace{\~n}ero and Juli{\'a}n Aragon{\'e}s and John W Huffman and Jos{\'e} Luis Jorcano and Manuel Guzm{\'a}n},
  journal={The FASEB Journal},
  year={2003},
  volume={17}
}
Cannabinoids, the active components of marijuana and their derivatives, induce tumor regression in rodents (8). However, the mechanism of cannabinoid antitumoral action in vivo is as yet unknown. Here we show that local administration of a nonpsychoactive cannabinoid to mice inhibits angiogenesis of malignant gliomas as determined by immunohistochemical analyses and vascular permeability assays. In vitro and in vivo experiments show that at least two mechanisms may be involved in this… 
The antitumor action of cannabinoids on glioma tumorigenesis.
TLDR
This work presents the available experimental and clinical data, to date, regarding the antitumor action of cannabinoids on the tumorigenesis of gliomas.
Pathway in Gliomas Cannabinoids Inhibit the Vascular Endothelial Growth Factor
Cannabinoids inhibit tumor angiogenesis in mice, but the mechanism of their antiangiogenic action is still unknown. Because the vascular endothelial growth factor (VEGF) pathway plays a critical role
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Cannabinoids inhibit tumor angiogenesis in mice, but the mechanism of their antiangiogenic action is still unknown. Because the vascular endothelial growth factor (VEGF) pathway plays a critical role
Cannabinoids and Gliomas
TLDR
The good safety profile of THC, together with its possible growth-inhibiting action on tumor cells, justifies the setting up of future trials aimed at evaluating the potential antitumoral activity of cannabinoids.
Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
TLDR
Manipulation of MMP-2 expression by RNA interference and cDNA overexpression experiments proved that down-regulation of this MMP plays a critical role in THC-mediated inhibition of cell invasion and constitutes a new hallmark of cannabinoid antitumoral activity.
Cannabinoids as Potential Antitumoral Agents in Pancreatic Cancer
TLDR
The fair safety profile of THC, together with its possible growth-inhibiting action on tumor cells, may set the basis for future trials aimed at evaluating the potential antitumoral activity of cannabinoids in other types of tumors such as pancreatic adenocarcinomas.
Anticancer mechanisms of cannabinoids.
TLDR
The current understanding of cannabinoids as antitumour agents is discussed, focusing on recent discoveries about their molecular mechanisms of action, including resistance mechanisms and opportunities for their use in combination therapy.
Cannabinoids: potential antitumoral agents?
TLDR
The fair safety profile of THC, together with its possible growth-inhibiting action on tumor cells, may set the basis for future trials aimed at evaluating the potential antitumoral activity of cannabinoids.
Cannabidiol inhibits angiogenesis by multiple mechanisms
TLDR
The ability of CBD to modulate tumour angiogenesis is evaluated and it is found that it effectively inhibits the growth of different types of tumours in vitro and in vivo and down‐regulates some pro‐angiogenic signals produced by glioma cells.
...
...

References

SHOWING 1-10 OF 49 REFERENCES
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
TLDR
It is shown that intratumoral administration of Δ9-tetrahydrocannabinol and the synthetic cannabinoid agonist WIN-55,212-2 induced a considerable regression of malignant gliomas in Wistar rats and in mice deficient in recombination activating gene 2.
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
TLDR
It is shown that local administration of the selective CB(2) agonist JWH-133 at 50 microg/day to Rag-2(-/-) mice induced a considerable regression of malignant tumors generated by inoculation of C6 glioma cells, and showed that selective activation of the CB( 2) receptor signaled apoptosis via enhanced ceramide synthesis de novo.
Control of the cell survival/death decision by cannabinoids
TLDR
The neuroprotective effect of cannabinoids may have potential clinical relevance for the treatment of neurodegenerative disorders such as multiple sclerosis, Parkinson's disease, and ischemia/stroke, whereas their growth-inhibiting action on transformed cells might be useful for the management of malignant brain tumors.
Control by the endogenous cannabinoid system of ras oncogene‐dependent tumor growth
  • M. Bifulco, C. Laezza, V. Di Marzo
  • Biology, Medicine
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2001
TLDR
The data suggest that Met‐F‐AEA inhibits ras oncogene‐dependent tumor growth in vivo through CB1 cannabinoid receptors; and responsiveness of FRTL‐5 cells to endocannabinoids depends on whether or not they are transformed by K‐ras.
The endocannabinoid system as a target for therapeutic drugs.
Ceramide: a new second messenger of cannabinoid action.
The endocannabinoid nervous system: unique opportunities for therapeutic intervention.
Molecular characterization of a peripheral receptor for cannabinoids
TLDR
The cloning of a receptor for cannabinoids is reported that is not expressed in the brain but rather in macrophages in the marginal zone of spleen, which helps clarify the non-psychoactive effects of cannabinoids.
Antineoplastic activity of cannabinoids.
TLDR
Delta9-THC administered orally daily until death in doses of 50, 100, or 200 mg/kg did not increase the life-spans of (C57BL/6 times DBA/2)F1 (BDF1) mice hosting the L1210 murine leukemia, however, delta9- THC administered daily for 10 days significantly inhibited Friend leukemia virus-induced splenomegaly.
Clinical applications of angiogenic growth factors and their inhibitors
TLDR
Inhibition of the action of key regulators of angiogenesis, such as VEGF, constitutes a promising approach for the treatment of solid tumors and intraocular neovascular syndromes.
...
...